CA45422-4A - 0x00000000000067A9

Healthy Males & Females

Alchemy

* Stipend may pay up to reflected amount.
Start Date: 
January 2, 2026 - 6:30am
End Date: 
April 23, 2026 - 9:30am

Study Details

Study Number: CA45422
Group Number: 4A
Study Requirement: Healthy Normal Male and Female
Stipend: up to $10,500.00

Study Criteria

Age: 19 - 65
BMI: 18 - 32
Weight Restriction: minimum weight 110 lbs

Study Information

Indication: This investigational medication is being developed to treat ALS (often called Lou Gehrig's disease) which causes muscle weakness and paralysis.
Route of Administration: Injection IV infusion
Blood Draws: 22

Study Schedule

Schedule Type: Short stays with returns
Study Length: 4- Night Stay, 6 Returns & 1 Phone Call

Screening Dates:

Event Day Event Date
Wednesday 12/17/2025
Friday 12/19/2025
Monday 12/22/2025
Monday 12/29/2025

Doctor Exam Dates:

Event Day Event Date
Wednesday 12/17/2025
Friday 12/19/2025
Monday 12/22/2025
Monday 12/29/2025

Study Dates:

Event Type Start Day Start Date End Day End Date Phase Site
Return Friday 1/2/2026 6:30:00 AM Friday 1/2/2026 8:15:00 AM 1L Lincoln
Check-In Wednesday 1/7/2026 2:00:00 PM Sunday 1/11/2026 8:30:00 AM 1 Lincoln
Phone participant Friday 1/16/2026 11:30:00 AM 1 Lincoln
Return Friday 1/23/2026 7:30:00 AM Friday 1/23/2026 8:30:00 AM 1 Lincoln
Return Thursday 2/5/2026 7:30:00 AM Thursday 2/5/2026 8:30:00 AM 1 Lincoln
Return Thursday 3/5/2026 7:30:00 AM Thursday 3/5/2026 8:30:00 AM 1 Lincoln
Return Thursday 3/26/2026 8:30:00 AM Thursday 3/26/2026 9:30:00 AM 1 Lincoln
Return Thursday 4/23/2026 8:30:00 AM Thursday 4/23/2026 9:30:00 AM 1 Lincoln